Skip 
Navigation Link
Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
FDA May Limit 'Risk Info' in Direct-to-Consumer TV Drug AdsFDA Announces Recall of Some Liquid Pharmaceutical ProductsIs FDA Taking Close Enough Look at Fast-Tracked Drugs?Steep Price Hikes Led to Drop in Use of 2 Heart Drugs at U.S. HospitalsAPA: Medical Discrimination Based on Size Stresses Patients2 of 3 U.S. Patients Keep Unused Painkillers After SurgeryMedical Reality Catches Up to Science FictionFDA Looks to Reduce Nicotine in CigarettesAHA Hands-Only CPR Training Kiosks Available at More Airports$100 Sweetens the Pot for a ColonoscopyJust a Few Vaccine Refusers Could Endanger ManyASCO Addresses Cancer Drug PricingHigh Court Rules Against Interstate Medical LiabilityFewer U.S. Dollars Spent on Cardiac Arrest Research: StudyPainkiller Prescriptions More Prone to Errors If HandwrittenFDA Panel OKs What May Soon Be First Gene Therapy Approved in U.S.Walking Rates Are Key to a Country's Obesity LevelsDocs Should Counsel Even Healthy People on Diet, Exercise, Experts SayHealth Service Use Unchanged From 1996-1997 to 2011-2012Easier Colon Exam Boosts Screening, But Insurers May Not PayMore U.S. Patients Are Recording Their Doctor VisitsMedication Mistakes Have Doubled in U.S. Since 2000: StudyPatient Involvement Can Cut Errors in X-Ray ImagingMarket Competition Linked to Change in Generic Drug PricesBlood Shortage Prompts Call for DonationsBullying Takes Financial Toll on U.S. School DistrictsPoll Finds Seniors Struggling With Drug Costs Don't Seek HelpMany U.S. Teens Still Denied 'Morning After' Pill at PharmaciesOlder Americans Struggling With Drug Costs Don't Ask for HelpDoctors Urged to Take Care With Electronic CommunicationsClimate Change Likely to Widen Gap Between Rich, Poor in U.S.: StudyFDA Seeks to Increase Number of Generic Drugs on Market3 Simple Steps Might Reduce Opioid OD DeathsPhysician Attitude Important Factor in Patients Switching PCPMany Adverse Events Related to Cosmetics Go UnreportedStudy Highlights the Beauty Industry's Ugly SideMedicaid Cuts Tied to Delayed Breast Cancer DiagnosesPrimary Care Pharmacy Model Attractive to Patients1991-2014 Saw Minimal Change in Health Spending Per StateLegalized Pot May Lead to More Traffic CrashesMany Doctors Silent on Cost of Cancer CareGroup Urges Tougher Limits on Chemical in Shampoos, Cosmetics18 Percent Increase Projected in Primary Care Demand by 2023Why Patients Leave the Hospital Against Doctor's OrdersRaise the Smoking Age to 21? Most Kids Fine With ThatComprehensive Audiologic Care Feasible in Free Clinic ModelMany Tanning Salons Defy Legal Age Limits on UsersLifesaving Drugs From Pfizer in Short Supply: FDALeading U.S. Doctors' Group Takes Aim at Rising Drug PricesU.S. Hospitals Still Prescribe Too Many Antibiotics: Study
Questions and AnswersLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Checking Patient's Drug History May Help Curb Opioid Abuse

HealthDay News
by -- Mary Elizabeth Dallas
Updated: May 23rd 2017

new article illustration

TUESDAY, May 23, 2017 (HealthDay News) -- Doctors can help stem the U.S. opioid epidemic by checking their patients' drug history before prescribing powerful painkillers, a new study suggests.

Addicts frequently "doctor-shop" in an attempt to obtain opioids such as OxyContin (oxycodone), Percocet (oxycodone/acetaminophen) and Vicodin (hydrocodone/acetaminophen).

But, nearly every state now has a database tracking opioid prescriptions, Cornell University researchers said. Doctors can use these databases to check their patients' past prescriptions and identify likely drug abusers.

"The main issue is getting providers to change their prescribing behavior. The majority of opioids that people abuse start in the medical system as a legitimate prescription," said study co-author Colleen Carey. She's an assistant professor of policy analysis and management at Cornell's College of Human Ecology in Ithaca, N.Y.

However, prescription databases only help combat drug abuse when doctors are required by law to check them before writing prescriptions, Carey and her colleagues noted in a university news release.

The researchers found that states that enforced a "must access" policy for prescription drug databases saw a drop in the number of Medicare recipients who got more than a seven-months' supply of medication in just six months. Also, fewer people filled a prescription before their previous supply ran out.

According to the study, the number of Medicare opioid users who received prescriptions from five or more doctors dropped by 8 percent in those states. And the number of people who got opioids from five or more pharmacies fell by more than 15 percent.

The effects of prescription database regulations were most notable in states with the strictest laws, including New York, the researchers said.

New York requires doctors to check the opioid history of "every patient, every time," the researchers said. But even less stringent state laws reduced doctor-shopping, the study found.

The study looked only at Medicare recipients, but the researchers said their findings apply to the general population. They noted, however, that patients who abuse opioids could travel to a state with fewer regulations to more easily obtain their drugs.

The findings will be published in a future issue of American Economic Journal: Economic Policy.

More information

The U.S. National Institute on Drug Abuse provides more information on opioids.